TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: changes to the oral and nasal microbiota
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse events evaluation
Endpoint domain: Adverse events/effects
Primary endpoint: spontaneous conversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall recurrence rate at two years
Endpoint domain: Adverse events/effects
Primary endpoint: PDA-related BPD rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: NEC rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Need for ligation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: plasma u-hscTnI levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: safety and efficacy of DAPT regimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lipid goals achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety issues of evolocumab and alirocumab
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in terminology score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improvement in practice score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: blood pressure-lowering effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of PVR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neurodevelopmental disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemagglutination inhibition (HAI) fold change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HAI geometric mean titer (GMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: antigen-specific antibody-secreting cells (ASC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ADL outcomes improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discontinuation of treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: risk of acute confusional state
Endpoint domain: Adverse events/effects
Primary endpoint: visual outcome after RD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCMC score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: P1 amplitude improvement of mf-ERG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apolipoprotein B48 in chylomicrons
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Triglyceride in VLDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recovery assessed with an activity tracker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (RAND SF-36 score)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: somatic damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of SARS-CoV-2 and influenza-A infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of responders after 12 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: AKI stage classification by urine output criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: dysfonction nerveuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: weight outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anastomotic leak detection sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anastomotic test pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of premedication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance of premedication
Endpoint domain: Adverse events/effects
Primary endpoint: Need for unplanned or emergency surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of HDL proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ICVCI (Indice de Compression de la Veine Cave Inférieure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Root Mean Square Successive Differences (RMSSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of FRED flow diverter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety of FRED flow diverter
Endpoint domain: Adverse events/effects
Primary endpoint: Postnatal clinical severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postnatal clinical severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: perinatal coronavirus transmission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coronavirus-related embryopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diameter and ratio of bilateral A1, M1, and internal carotid artery (ICA) vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: ratio of the PED size (sPED) to the ipsilateral ICA (I-ICA) diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: mean reduction of adenoma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: resolution of LUTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wait-list mortality
Endpoint domain: Mortality/survival
Primary endpoint: Failed delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Any maternal trauma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Third- or fourth-degree tears
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: P falciparum parasitaemia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: P vivax parasitaemia prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: thromboembolic events
Endpoint domain: Mortality/survival
Primary endpoint: Number of CXRs performed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of UTI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: long-term neurological outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: WOMAC stiffness index decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC daily functioning index decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: capacité de fécondation des spermatozoïdes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: proportion de spermatozoïdes vivants et progressivement mobiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: pourcentage de spermatozoïdes présentant une décondensation de la chromatine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: all-cause hospitalisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: first sleep cycle duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rapid eye movement (REM) percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taux de testostérone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Taux d’androstènedione
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: episodes of rotavirus diarrhoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24h ABPM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: diastolic office-measured BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduction in severity (response) of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of people exhibiting more than 1% B-cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Disease-breakthrough rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sphincter abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alterations in rectal sensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-compliant care pathways
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Unnecessary PED visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Niveaux de bruit moyens lors de l’induction de l’anesthésie
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction des anesthésiologistes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Capacité perçue des anesthésiologistes à réaliser leurs tâches
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: olfactory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart failure-related rehospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: all-cause rehospitalisation
Endpoint domain: Mortality/survival
Primary endpoint: risk of new initiation of renal replacement therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mortality within four months of surgery
Endpoint domain: Mortality/survival
Primary endpoint: Non-union rate
Endpoint domain: Adverse events/effects
Primary endpoint: turnover time of the endoscopy room
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum klotho levels after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL1β and TNF-α levels after exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IL-6 level change in RA group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Influenza virus detection frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Basic Activities of Daily Living (BADL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological distress (Kessler-6 score ≥ 5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported mental health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Partial Response (PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: volume gastrique résiduel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Liver stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sBA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Total autism symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between HPV DNA assays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity and specificity of HPV detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of non-paroxysmal AF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHA2DS2-VASC and HAS-BLED scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prevalence of LAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary long-term outcome
Endpoint domain: Mortality/survival
Primary endpoint: troubles métaboliques et anthropométriques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incident persistent oncogenic HPV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Postoperative blood levels of adipokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PCR-adjusted treatment failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: episodes of abnormally raised ALT
Endpoint domain: Adverse events/effects
Primary endpoint: Functionally active pneumococcal antibodies post-PCV13 immunization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pulmonary embolism (PE) occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: NPi (Neurological Pupillary Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCP score (Hunt and Hess Coma Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: variceal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: nonbleeding hepatic decompensation events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Technique efficacy at 1-month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum level of sSIRPα
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between clinical diagnosis of sepsis and SOFA/SIRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effort-Reward Imbalance (ERI) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: agrément avec l’échographie traditionnelle
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MACE-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monitored adverse event-free days
Endpoint domain: Adverse events/effects
Primary endpoint: Mortalité à 30 jours
Endpoint domain: Mortality/survival
Primary endpoint: program completion rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Interobserver agreement for tumor volume delineations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: management of recovery and acute pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of normal olfactory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 7-day intensive care unit care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Recognition of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: staff well-being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CHA2DS2VASc score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Embolic activity detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Access to therapeutic hypothermia within 6 hours of life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic value of HRM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exclusivity of breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of women stopping breastfeeding at three to four months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO clinical progression scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenation-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality within 30, 90, and 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Readmission within 30, 90, and 180 days
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: severe clinical course after infection with SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incomplete resection rate (IRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Intraprocedural bleeding requiring endoscopic intervention
Endpoint domain: Adverse events/effects
Primary endpoint: skills knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of thrombotic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: 90-day mortality rate of late PPH
Endpoint domain: Mortality/survival
Primary endpoint: Volume liquidien du cou
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume liquidien des jambes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality risk associated with BMI categories
Endpoint domain: Mortality/survival
Primary endpoint: First-pass success of cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall success of cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of MRSA-negative respiratory cultures at day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence de dysfonctionnement persistant du diaphragme
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Effectiveness of paracetamol for PDA treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness in managing acute traumatic musculoskeletal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: limited exercise tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virologic markers of chronic HBV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Biochemical markers of chronic HBV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immunological markers of chronic HBV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: taux d'échecs thérapeutiques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion d'effets indésirables mineurs
Endpoint domain: Adverse events/effects
Primary endpoint: Prédiction de l'EP à 30 jours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean NASA TLX value
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean SUS value
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: motilité progressive des spermatozoïdes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: morphologie normale des spermatozoïdes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: OHIP-14 score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lesion resolution (Thongprasom score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social inclination
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Growth of hematopoietic progenitor cells (HPCs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Death (any cause and cardiovascular)
Endpoint domain: Mortality/survival
Primary endpoint: risk of peritonitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: risk of haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall Response Rate (ORR)
Endpoint domain: Adverse events/effects
Primary endpoint: Disease Control Rate (DCR)
Endpoint domain: Adverse events/effects
Primary endpoint: increase physical activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in-hospital mortality at 60 days
Endpoint domain: Mortality/survival
Primary endpoint: vasopressor duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SOFA score at 72 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in AMH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Irregularities in menstruation post-vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Reduction in recession height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes